Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
303 studies found for:    "Mesothelioma"
Show Display Options
RSS Create an RSS feed from your search for:
"Mesothelioma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Tomotherapy Treatment for Mesothelioma
Condition: Mesothelioma
Intervention: Procedure: Tomotherapy
2 Unknown 
Has Results
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Oxaliplatin/Gemcitabine
3 Unknown  Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin)
4 Completed
Has Results
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: gemcitabine hydrochloride;   Drug: carboplatin
5 Unknown  Vinorelbine in Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Vinorelbine;   Other: Active Symptom Control
6 Unknown  Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
7 Recruiting A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
Condition: Pleural Mesothelioma
Interventions: Drug: Pembrolizumab;   Drug: Cisplatin and Pemetrexed
8 Active, not recruiting Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
Condition: Mesothelioma
Interventions: Drug: Nivolumab;   Drug: Nivolumab + Ipilimumab
9 Completed Dendritic Cell-based Immunotherapy in Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: tumor lysate-loaded autologous dendritic cells
10 Unknown  Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
Condition: Malignant Mesothelioma
Interventions: Drug: chemotherapy;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
11 Recruiting PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Radiation: Prophylactic Irradiation of Tracts (PIT)
12 Completed Serum Biomarkers in Diagnosis of Mesothelioma
Condition: Mesothelioma
Intervention: Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1
13 Completed Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Erlotinib;   Drug: Bevacizumab
14 Completed Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Condition: Peritoneal Mesothelioma
Intervention: Genetic: comparative genomic analysis
15 Completed SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Biological: Multicycle SS1P;   Drug: Pemetrexed;   Drug: Cisplatin;   Biological: Single cycle SS1P
16 Withdrawn A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Vorinostat;   Drug: Placebo
17 Terminated Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
18 Terminated Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: trabectedin
19 Active, not recruiting
Has Results
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Pleural Mesothelioma;   Peritoneal Mesothelioma
Intervention: Drug: IMC-A12
20 Not yet recruiting Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Concurrent Durvalumab;   Drug: Maintenance Durvalumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.